Literature DB >> 19186006

Prevalence of infectious pathogens in Crohn's disease.

Thomas Knösel1, Christiane Schewe, Nanni Petersen, Manfred Dietel, Iver Petersen.   

Abstract

The importance of infectious pathogens in Crohn's disease (CD) is still under debate. Therefore, we examined a panel of potential viral and bacterial pathogens in a large series of CD patients and controls. Archival tissue from 76 patients, 56 with CD and 20 control patients, with normal colon mucosa (n=10) and non-steroid anti-inflammatory drug (NSAID)-induced colitis (n=10) were examined using PCR-based detection methods for human cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus 1, 2 (HSV1,2), adenovirus (AD), varicella-zoster virus (VZV), human herpes virus 6 (HHV6), human herpes virus 8 (HHV8), Mycobacterium tuberculosis complex (Mtbc), atypical mycobacteria (nM/MG1), including Mycobacterium avium (subspecies paratuberculosis, MAP), Stenotrophomonas maltophilia (Sm), and Yersinia enterocolitica (Ye). In CD patients, positive PCR results were achieved in 19 cases (34%). Sm was most frequent in 10 of 56 cases (17.9%) followed by EBV (6/56, 10.7%), nM/MG1 (4/56, 7.1%), including MAP, HHV6, and CMV (2/56, 3.6%), and finally Mtbc and AD (1/56, 1.8%). The control patients showed positive PCR results in 12 patients (12/20, 60%), nine of them with only weak signals, suggesting a persistent infection. In addition, we compared typical pathomorphological features of CD patients with the PCR results and found a significant correlation between EBV infection and mural abscesses (P=0.014). Our data demonstrate that several potential pathogens can be detected in a sizeable fraction of specimens from patients with CD, but also in control patients, suggesting that the analyzed infectious pathogens may be associated with the disease, but do not represent an obligatory cause.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186006     DOI: 10.1016/j.prp.2008.04.018

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  28 in total

1.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  CMV in moderately active colitis: much ado about nothing?

Authors:  Alan C Moss
Journal:  Dig Dis Sci       Date:  2010-04       Impact factor: 3.199

Review 3.  Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling.

Authors:  Michal Caspi Tal; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 4.  [Nonbacterial colitides].

Authors:  D E Aust; G B Baretton
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

5.  Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Authors:  Sandeep A Walujkar; Shreyas V Kumbhare; Nachiket P Marathe; Dhrati V Patangia; Parimal S Lawate; Renu S Bharadwaj; Yogesh S Shouche
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

Review 6.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 7.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

8.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Host responses to the pathogen Mycobacterium avium subsp. paratuberculosis and beneficial microbes exhibit host sex specificity.

Authors:  Enusha Karunasena; K Wyatt McMahon; David Chang; Mindy M Brashears
Journal:  Appl Environ Microbiol       Date:  2014-08       Impact factor: 4.792

10.  Symptoms and sources of Yersinia enterocolitica-infection: a case-control study.

Authors:  Elisa Huovinen; Leila M Sihvonen; Mikko J Virtanen; Kaisa Haukka; Anja Siitonen; Markku Kuusi
Journal:  BMC Infect Dis       Date:  2010-05-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.